De-Coupling Process Development from Manufacturing: Turning the Traditional CDMO Model on its Head
A paradigm shift is underway—one that decouples process development from manufacturing, fundamentally changing how biopharma companies approach Chemistry, Manufacturing & Control (CMC) (learn more). This approach prioritizes a deep scientific understanding of processes and gives medicine developers full ownership of the data and insights required for flexible, efficient, and resilient manufacturing.